Having previously demonstrated that activation of NK cells with IFNβ significantly increased their killing of NPC cells [12,16], we next asked the question, whether killing of NPC cells exposed to chemotherapeutic agents was further augmented when NK cells were activated. Here, IFNB1 is linked to nasopharyngeal carcinoma.